14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Wednesday, 15th Mar 2023 YMTX stock ended at $1.76. During the day the stock fluctuated 0% from a day low at $1.76 to a day high of $1.76.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Yumanity Therapeutics, Inc. prices

Date Open High Low Close Volume
Mar 15, 2023 $1.76 $1.76 $1.76 $1.76 0
Mar 14, 2023 $1.76 $1.76 $1.76 $1.76 0
Mar 13, 2023 $1.76 $1.76 $1.76 $1.76 0
Mar 10, 2023 $1.76 $1.76 $1.76 $1.76 0
Mar 09, 2023 $1.76 $1.76 $1.76 $1.76 0
Mar 08, 2023 $1.76 $1.76 $1.76 $1.76 0
Mar 07, 2023 $1.76 $1.76 $1.76 $1.76 0
Mar 06, 2023 $1.76 $1.76 $1.76 $1.76 0
Mar 03, 2023 $1.76 $1.76 $1.76 $1.76 0
Mar 02, 2023 $1.76 $1.76 $1.76 $1.76 0
Mar 01, 2023 $1.76 $1.76 $1.76 $1.76 0
Feb 28, 2023 $1.76 $1.76 $1.76 $1.76 0
Feb 27, 2023 $1.76 $1.76 $1.76 $1.76 0
Feb 24, 2023 $1.76 $1.76 $1.76 $1.76 0
Feb 23, 2023 $1.76 $1.76 $1.76 $1.76 0
Feb 22, 2023 $1.76 $1.76 $1.76 $1.76 0
Feb 21, 2023 $1.76 $1.76 $1.76 $1.76 0
Feb 17, 2023 $1.76 $1.76 $1.76 $1.76 0
Feb 16, 2023 $1.76 $1.76 $1.76 $1.76 0
Feb 15, 2023 $1.76 $1.76 $1.76 $1.76 0
Feb 14, 2023 $1.76 $1.76 $1.76 $1.76 0
Feb 13, 2023 $1.76 $1.76 $1.76 $1.76 0
Feb 10, 2023 $1.76 $1.76 $1.76 $1.76 0
Feb 09, 2023 $1.76 $1.76 $1.76 $1.76 0
Feb 08, 2023 $1.76 $1.76 $1.76 $1.76 0
Click to get the best stock tips daily for free!

About Yumanity Therapeutics, Inc.

Yumanity Therapeutics. Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis, and frontotemporal lobar degeneration. Its lead p... YMTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT